Redistribution of body composition in patients with Graves' disease after iodine-131 treatment

被引:5
|
作者
Xie, L-J [1 ]
Zhou, H-J [2 ]
Li, J-F [1 ]
Zhang, F. [1 ]
Zeng, F-W [1 ]
Qin, L-P [1 ]
Chen, Y. [1 ]
Yuan, H-J [1 ]
Cheng, M-H [1 ]
机构
[1] Sun Yat Sen Univ, Dept Nucl Med, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Dept Internal Med, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China
关键词
X-RAY ABSORPTIOMETRY; SERUM LEPTIN LEVELS; SKELETAL-MUSCLE; MASS INDEX; THYROID-HORMONE; RADIOIODINE TREATMENT; ENERGY-EXPENDITURE; HYPERTHYROIDISM; BONE; HYPOTHYROIDISM;
D O I
10.1038/ejcn.2014.232
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
OBJECTIVE: The objective of this study was to investigate body composition redistribution at 3 months after radioactive iodine therapy (RAI). METHODS: Eighty patients with Graves' disease (GD) for RAI and 18 volunteers were recruited. All patients underwent thyroid status test and dual-energy x-ray absorptiometry at baseline and 3 months after RAI. According to the second thyroid status test, patients were divided into the following groups: A, with aggravated hyperthyroidism; B-1, with improved hyperthyroidism; B-2, with euthyroidism; and B-3, with hypothyroidism. RESULTS: Total lean mass (LM) but fat mass (FM) and bone mineral content (BMC) of whole GD patients after RAI recovered to be not different with controls. Compared with baseline, in group A, FM in the left leg increased, and LM in left arm, right arm, trunk and total LM decreased (P<0.05). In B-2, FM in the head increased, and LM in the head, right arm, trunk and total LM increased (P<0.05). In B-3, FM in the right leg and total body fat percentage decreased, but FM in the head, android-to-gynoid fat ratio and body mass index increased (P<0.05); LM of all sites, weight and total mass increased (P<0.05); BMC in lumbar spine and left leg, and total BMC decreased (P<0.05). Body composition of unmentioned sites was retained after RAI in each group (P>0.05). CONCLUSIONS: Replenishment of LM gets priority rather than FM and BMC during the first 3 months after RAI, and the increase in LM starts from the upper body; head is the regional site in which FM recovery occurs first.
引用
收藏
页码:856 / 861
页数:6
相关论文
共 50 条
  • [41] Weight Gain and Body Composition Changes during the Transition of Thyroid Function in Patients with Graves' Disease Undergoing Radioiodine Treatment
    Cai, Zhenqin
    Chen, Qiyu
    Ling, Yan
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2022, 2022
  • [42] A comparative study of influential factors correlating with early and late hypothyroidism after 131I therapy for Graves' disease
    Wang Ren-fei
    Tan Jian
    Zhang Gui-zhi
    Meng Zhao-wei
    Zheng Wei
    CHINESE MEDICAL JOURNAL, 2010, 123 (12) : 1528 - 1532
  • [43] The Prevalence, Magnitude, and Reversibility of Elevated Liver Enzyme Activities in Hyperthyroid Cats Presenting for Iodine-131 Treatment
    Campbell, Joseph
    Chapman, Peter
    Klag, Alan
    FRONTIERS IN VETERINARY SCIENCE, 2022, 9
  • [44] Predictive Factors for the Efficacy of Radioactive Iodine Treatment of Graves' Disease
    Feng, Wenwen
    Shi, He
    Yang, Yanli
    Liu, Jing
    Chen, Shiying
    Ren, Minghui
    Li, Yajie
    Liu, Wei
    Cui, Dai
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2024, 2024
  • [45] A Randomized Controlled Trial to Evaluate the Effectiveness of 2 Regimens of Fixed Iodine (131I) Doses for Graves Disease Treatment
    Santos, Roberto B.
    Romaldini, Joao H.
    Ward, Laura S.
    CLINICAL NUCLEAR MEDICINE, 2012, 37 (03) : 241 - 244
  • [46] Effects of Hypothyroidism on Quality of Life of Differentiated Thyroid Carcinoma Patients undergoing Postoperative Iodine-131 Therapy
    Wang, Yaoyao
    Shen, Xingping
    Yang, Fan
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 83 (01) : 127 - 133
  • [47] THE OCCURRENCE OF ACUTE PANCREATITIS AFTER IODINE 131 TREATMENT OF HYPERTHYROIDISM
    Liu, Y.
    Lou, X.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2022, 18 (02) : 250 - 251
  • [48] Adjuvant lithium improves the efficacy of radioactive iodine treatment in Graves' and toxic nodular disease
    Martin, Niamh M.
    Patel, Miraj
    Nijher, Gurjinder M. K.
    Misra, Shivani
    Murphy, Elaine
    Meeran, Karim
    CLINICAL ENDOCRINOLOGY, 2012, 77 (04) : 621 - 627
  • [49] Analysis of 131I therapy and correlation factors of Graves' disease patients: a 4-year retrospective study
    Wei Zheng
    Tan Jian
    Zhang Guizhi
    Meng Zhaowei
    Wang Renfei
    NUCLEAR MEDICINE COMMUNICATIONS, 2012, 33 (01) : 97 - 101
  • [50] Cancer Risk in Graves Disease with Radioactive 131I Treatment: A Nationwide Cohort Study
    Kim, Kyeong Jin
    Choi, Jimi
    Kim, Kyoung Jin
    Song, Eyun
    Yu, Ji Hee
    Kim, Nam Hoon
    Yoo, Hye Jin
    Seo, Ji A.
    Kim, Nan Hee
    Choi, Kyung Mook
    Baik, Sei Hyun
    Kim, Sin Gon
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (05) : 693 - 699